Previous 10 | Next 10 |
2024-01-02 17:52:42 ET DENVER, Colo., Jan. 2, 2024 ( www.247marketnews.com )- 24/7 Market News covered the following companies today; Longboard Pharmaceuticals Inc (NASDAQ: LBPH), Voyager Therapeutics Inc (NASDAQ: VYGR), Polished.com Inc (AMEX: POL), C4 Therapeutics Inc. (NASDAQ: CCCC),...
2024-01-02 16:55:53 ET Gainers: Bloomin' Brands ( BLMN ) +6% . Arcutis Biotherapeutics ( ARQT ) +6% . Stronghold Digital Mining ( SDIG ) +5% . Longboard Pharmaceuticals ( LBPH ) +4% . Guardant Health ( GH ) +3% . Losers: ...
2024-01-02 16:31:09 ET More on Longboard Pharmaceuticals Longboard stock soars 132% in premarket trading on positive data Seeking Alpha’s Quant Rating on Longboard Pharmaceuticals Historical earnings data for Longboard Pharmaceuticals Financial informa...
2024-01-02 12:56:48 ET More on Mid-day movers & stocks. ENDRA Life Sciences Inc. (NDRA) Q3 2023 Earnings Call Transcript PolyPid Ltd. (PYPD) Q3 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Endra Life Sciences Historical earnings da...
2024-01-02 10:09:39 ET DENVER, Colo., Jan. 2, 2024 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Longboard Pharmaceuticals Inc (NASDAQ: LBPH), Voyager Therapeutics Inc (NASDAQ: VYGR), Soligenix Inc (NASDAQ: ...
2024-01-02 08:58:56 ET DENVER, Colo., Jan. 2, 2024 ( www.247marketnews.com )- Longboard Pharmaceuticals Inc (NASDAQ: LBPH) reported, this morning, that it’s rapidly moving forward with preparations for its global Phase 3 program, after achieving positive topline data from the PAC...
2024-01-02 08:46:54 ET More on Longboard Pharmaceuticals Seeking Alpha’s Quant Rating on Longboard Pharmaceuticals Historical earnings data for Longboard Pharmaceuticals Financial information for Longboard Pharmaceuticals For further details see: L...
Bexicaserin achieved a median seizure reduction of 53.3% in countable motor seizures compared to 20.8% in the placebo group across the DEE study population A median seizure reduction of 72.1% in Dravet Syndrome (DS), 48.1% in Lennox-Gastaut Syndrome (LGS) and 61.2% in DEE Other was achiev...
• Conference call and webcast to be held tomorrow, January 2, at 8:30am ET (5:30am PT) Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced...
Initiated Single-Ascending Dose (SAD) Phase 1 clinical study evaluating LP659 Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced the initiation ...
News, Short Squeeze, Breakout and More Instantly...
Longboard Pharmaceuticals Inc. Company Name:
LBPH Stock Symbol:
NASDAQ Market:
Longboard Pharmaceuticals Inc. Website:
Conference call to discuss corporate updates, including Phase 1 single ascending dose (SAD) topline data for LP659 in healthy volunteers Conference call and webcast to be held August 1 at 4:30pm ET (1:30pm PT) Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-st...
2024-07-16 13:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-06 15:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...